Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solio Bio is an active private biotech skincare company developing and commercializing 100% bio-based, clinically validated sun care and skincare products. The company appears focused on biomimetic, reef-safe ultraviolet protection inspired by marine organisms, using biotechnology to produce cleaner alternatives to petrochemical-based sunscreen ingredients. Publicly available information suggests it is a vertically integrated consumer biotech company rather than a therapeutic drug developer, with an emphasis on safer skin and environmental profiles. Solio Bio therefore sits at the intersection of biotechnology, dermatology-adjacent consumer health, and sustainable ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solio.